Form 4: Biohaven CEO Vlad Coric Acquires Shares Following Merger
SEC Form 4
Biohaven CEO Vlad Coric reports acquisition of common shares on March 8, 2024, following a merger agreement.
Summary
- On March 8, 2024, Biohaven CEO Vlad Coric acquired common shares of Biohaven Ltd.
- The acquisition was made pursuant to a merger agreement dated January 7, 2024.
- Coric acquired 2,162 shares directly and holds 1,666,234 shares directly.
- Coric also has indirect ownership through The Vlad Coric Family Trust (840,659 shares), The Vladimir Coric Marital Trust (406,982 shares), and a 401(k) plan (109,565 shares).
Sentiment
Score: 6
Explanation: Neutral sentiment as the document primarily reports a transaction related to a merger agreement. The CEO's share acquisition could be seen as a positive sign, but it's part of a pre-planned event.
Positives
- The acquisition of shares by the CEO could be seen as a positive signal, indicating confidence in the company's future.
Industry Context
Share acquisitions by key executives are often monitored as indicators of company performance and management confidence within the pharmaceutical industry.
Stakeholder Impact
- The share acquisition could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| January 7, 2024 | Date of the merger agreement |
| March 8, 2024 | Date of the share acquisition by Vlad Coric |
| May 31, 2023 | Date of acquisition of 305 shares through the Biohaven Employee Share Purchase Plan |
| November 30, 2023 | Date of acquisition of 1,336 shares through the Biohaven Employee Share Purchase Plan |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.